* Pulmonx Corp LUNG.OQ LUNG.O is expected to show a rise
in
quarterly revenue when it reports results on February 21 for
the period ending December 31 2023
* The Redwood City California-based company is expected to
report
a 18.5% increase in revenue to $18.273 million from $15.43
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Pulmonx Corp is for a
loss
of 41 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$15.00, above its last closing price of $14.32.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.42 -0.43 -0.39 Beat 8.8
Jun. 30 2023 -0.44 -0.44 -0.43 Beat 1.6
Mar. 31 2023 -0.44 -0.44 -0.42 Beat 4.5
Dec. 31 2022 -0.43 -0.42 -0.38 Beat 8.7
Sep. -0.40 -0.40 -0.38 Beat 4.2
30 2022
Jun. 30 2022 -0.42 -0.41 -0.40 Beat 2.4
Mar. 31 2022 -0.38 -0.37 -0.43 Missed -15.9
Dec. 31 2021 -0.36 -0.36 -0.35 Beat 2.9
This summary was machine generated February 19 at 21:33 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)